Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29867 | ZNF423 Knockout cell line (HeLa) | Human | ZNF423 | 1:3~1:6 | Negative | Online Inquiry |
ZNF423 Gene Knockout Cell Lines are meticulously developed cellular models in which the ZNF423 gene, known for encoding a zinc-finger transcription factor involved in various cellular processes, has been inactivated. Through the application of advanced CRISPR-Cas9 gene editing techniques, these cell lines serve as invaluable tools for investigating the functional role of ZNF423 in pathways such as cell proliferation, differentiation, and response to stress, making them a significant asset for both basic and applied biological research.
The core functionality of ZNF423 gene knockout cell lines lies in their ability to elucidate the consequences of ZNF423 gene disruption. By providing a controlled environment where the gene is specifically inactivated, researchers can dissect downstream signaling pathways and gene expression changes associated with the loss of ZNF423 functionality. This mechanism allows for the exploration of disease models, particularly in cancer research, where ZNF423 has been implicated in tumorigenesis and therapeutic responses.
Scientifically, these knockout cell lines have profound implications in both research and clinical settings. They facilitate the study of genetic contributions to disease, enable drug discovery efforts, and help in the identification of potential therapeutic targets. Moreover, the ZNF423 knockout model can be employed for high-throughput screening, aiding in the rapid identification of compounds that can modulate gene function and influence cellular phenotypes.
One of the primary advantages of ZNF423 Gene Knockout Cell Lines is their precision and reliability compared to traditional loss-of-function experiments, which may involve broader genetic alterations or non-specific manipulation methods. In contrast, these engineered lines provide specificity for the ZNF423 gene, ensuring that observed effects can be confidently attributed to its knockout.
For researchers and clinicians seeking to deepen their understanding of gene function and the molecular underpinnings of various diseases, ZNF423 Gene Knockout Cell Lines offer a unique opportunity. The ability to generate reproducible and controllable experimental conditions is crucial for advancing knowledge and developing interventions in medicine.
With extensive experience in biotechnological innovations, our company is committed to providing high-quality biological products, including state-of-the-art gene knockout models that empower your research initiatives and propel scientific discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.